Advancing Scientific Breakthroughs and Empowering Parkinson’s Disease Research Since 1961, APDA has been a funding partner in many major...see more
Trichloroethylene and Parkinson’s Disease Risk
TCE and Parkinson’s disease risk Like most chronic diseases, the chance of developing Parkinson’s disease (PD) is due to...see more
Highlights from APDA-funded Parkinson’s Research: 2023 Update
APDA-Funded Research Projects: 2023 Update Since 1961, APDA has been a funding partner in many major scientific breakthroughs and...see more
Meet Dr. Stephan Grimaldi: an APDA-funded Researcher Working to Use MRI Imaging as a Possible Biomarker for Early Parkinson’s Disease
A Closer Look: Interview with APDA Researchers Our A Closer Look blog is designed to educate, inform, and inspire you through...see more
Tracking the Impact of APDA-funded Parkinson’s Research
APDA and Research Projects: Making a Difference APDA proudly invests in the most promising clinicians and scientific projects focused...see more
Cognition and Parkinson’s Disease Q&A
Questions About Parkinson’s Disease & Cognitive Impairment Changes in cognition can unfortunately be a common non-motor symptom of Parkinson’s...see more
Probiotics and Parkinson’s Disease
What the latest science tells us about probiotics & Parkinson’s disease People often ask us about the use of...see more
APDA’s Newly Funded 2023 Research Awardees
On September 8, 2022, APDA announced 27 new research grants for the year ahead. Our grant recipients are working tirelessly to...see more
Parkinson’s Research Pipeline: Medication for Cognition on the Horizon
Potential new medications for Parkinson’s cognitive decline With Parkinson’s disease (PD), cognitive issues are quite common. Yet, there are...see more
APDA-Funded Parkinson’s Research Successes: 2022 Update
APDA-funded Parkinson’s Research Successes: 2022 Update Since 1961, APDA has been a funding partner in many major scientific breakthroughs...see more